Publication Cover
Psychosis
Psychological, Social and Integrative Approaches
Volume 12, 2020 - Issue 4
115
Views
0
CrossRef citations to date
0
Altmetric
First Person Accounts

“I remember…so, let’s not forget”: remembering our past lest we repeat it

Pages 368-376 | Received 20 Apr 2020, Accepted 21 Apr 2020, Published online: 30 Apr 2020

References

  • Angermeyer, M., & Matschinger, H. (2005). Causal beliefs and attitudes to people with schizophrenia: Trend analysis based on data from two population surveys in Germany. British Journal of Psychiatry, 186(4), 331–334. https://doi.org/10.1192/bjp.186.4.331
  • Bennett, L., Thirlaway, K., & Murray, A. J. (2008). The stigmatizing implications of presenting schizophrenia as a genetic disease. Journal of Genetic Counseling, 17(6), 550–559. https://doi.org/10.1007/s10897-008-9178-8
  • Bockoven, J. S. (1972). Moral treatment in community health. Springer.
  • Bowers, M. (1974). Central dopamine turnover in schizophrenic syndromes. Archives of General Psychiatry, 31(1), 50–54. https://doi.org/10.1001/archpsyc.1974.01760130034005
  • Breggin, P. R. (1991). Toxic psychiatry. St. Martin’s Press.
  • Burt, D. R., Creese, I., & Snyder, S. H. (1977). Antischizophrenic drugs: Chronic treatment elevates dopamine receptor binding in brain. Science, 196(4287), 326–328. https://doi.org/10.1126/science.847477
  • Carlton, T., Ferriter, M., Huband, N., & Spandler, H. (2008). A systematic review of the Soteria paradigm for the treatment of people diagnosed with schizophrenia. Schizophrenia Bulletin, 34(1), 181–192. https://doi.org/10.1093/schbul/sbm047
  • Cartwright, S. (1851). Report on the diseases and physical peculiarities of the Negro race. New Orleans Medical and Surgical Journal, 7, 691–715.
  • Chouinard, G., & Jones, B. D. (1980). Neuroleptic-induced supersensitivity psychosis: Clinical and pharmacological characteristics. American Journal of Psychiatry, 137(1), 16–21. https://doi.org/10.1176/ajp.137.1.16
  • Deacon, B. J., & Grayson, L. B. (2009). The chemical imbalance explanation of depression: Reducing blame at what cost? Journal of Social and Clinical Psychology, 28(4), 415–435. https://doi.org/10.1521/jscp.2009.28.4.415
  • El-Hai, J. (2005). The lobotomist: A maverick medical genius and his tragic quest to rid the world of mental illness. John Wiley and Sons, Inc.
  • Fenton, W. S., & McGlashan, T. H. (1987). Sustained remission in drug-free schizophrenic patients. American Journal of Psychiatry, 144(10), 1306–1309. https://doi.org/10.1176/ajp.144.10.1306
  • Goffman, E. (1963). Stigma: Notes on the management of a spoiled identity. Prentice Hall.
  • Greenberg, R. P., Bornstein, R. F., Zborowski, J., Fisher, S., & Greenberg, M. D. (1994). A meta-analysis of Flueoxetine outcome in the treatment of depression. The Journal of Nervous and Mental Disease, 182(10), 547–551. https://doi.org/10.1097/00005053-199410000-00003
  • Greenberg, R. P., & Fisher, S. (1994). Seeing through the double-masked design: A commentary. Controlled Clinical Trials, 15(4), 244–246. https://doi.org/10.1016/0197-2456(94)90041-8
  • Greenblatt, M., Grosser, G. H., & Wechsler, H. (1964). Differential response of hospitalized depressed patients to somatic therapy. The American Journal of Psychiatry, 120(10), 935–943. https://doi.org/10.1176/ajp.120.10.935
  • Grubaugh, A. L., Zinzow, H. M., Paul, L., Egede, L. E., & Frueh, B. C. (2011). Trauma exposure and posttraumatic stress disorder in adults with severe mental illness: A critical review. Clinical Psychology Review, 31(6), 883–899. https://doi.org/10.1016/j.cpr.2011.04.003
  • Haefner, H., & An der Heiden, W. (1997). Are mental disorders increasing over time? Canadian Journal of Psychiatry, 42(2), 139–151. https://doi.org/10.1177/070674379704200204
  • Harding, C. M. (1988, July). Chronicity in schizophrenia. Paper delivered at the International Association of Psychosocial Rehabilitation Services Conference, Philadelphia, PA.
  • Harrow, M., & Jobe, T. H. (2007). Factors involved in outcome and recovery in schizophrenia patients not on antipsychotic medications: A 15-year follow-up study. The Journal of Nervous and Mental Disease, 195(5), 404–414. DOI: 10.1097/01.nmd.0000253783.32338.6e
  • Holley, L. C., Tavassoli, K. Y., & Stromwall, L. K. (2016). Mental illness discrimination in mental health treatment programs: Intersections of race, ethnicity, and sexual orientation. Community Mental Health Journal, 52(3), 311–322. https://doi.org/10.1007/s10597-016-9990-9
  • Jacobs, T. J. (1986). On countertransference enactments. Journal of the American Psychoanalytic Association, 34(2), 289–307. https://doi.org/10.1177/000306518603400203
  • Karon, B. P. (2001). The fear of understanding schizophrenia and iatrogenic myths. Journal of Contemporary Psychotherapy, 31(1), 15–20. https://doi.org/10.1023/A:1010222713883
  • Karon, B. P., & VandenBos, G. R. (1981). Psychotherapy of schizophrenia: The treatment of choice. Jason Aronson.
  • Kirsch, L., & Sapirstein, G. (1998). Listening to Prozac but hearing placebo: A meta-analysis of antidepressant medication. Prevention & Treatment, 1(2), 1–16. https://doi.org/10.1037/1522-3736.1.1.12a
  • Kopeloff, N., & Kirby, G. H. (1923). Focal infection and mental disease. American Journal of Psychiatry, 3(2), 150–197. https://doi.org/10.1192/bjp.71.292.144-a
  • Leff, J., Sartorius, N., Jabelensky, A., Korten, A., & Ernberg, G. (1992). The International Pilot Study of Schizophrenia: Five-year follow-up findings. Psychological Medicine, 22(1), 131–145. https://doi.org/10.1017/S0033291700032797
  • Leitner, L. M., & Celentana, M. A. (1997). Constructivist therapy with serious disturbances. The Humanistic Psychologist, 25(3), 271–285. https://doi.org/10.1080/08873267.1997.9986886
  • Lombardo, P. A. (1985). Three generations, no imbeciles: New light on Buck V. Bell. New York University Law Review, 60(1), 30–62.
  • MacKay, A. V., Iversen, L. L., Rossor, M., Spokes, E., Bird, E., Arregui, A., Creese, I., & Snyder, S. H. (1982). Increased dopamine and dopamine receptors in schizophrenia. Archives of General Psychiatry, 39(9), 991–997. https://doi.org/10.1001/archpsyc.1982.04290090001001
  • Matthews, S. M., Roper, M. T., Mosher, L. R., & Menn, A. Z. (1979). A non-neuroleptic treatment for schizophrenia: Analysis of the two-year postdischarge risk of relapse. Schizophrenia Bulletin, 5(2), 322–332. https://doi.org/10.1093/schbul/5.2.322
  • Mayes, R., & Horwitz, A. (2005). DSM-III and the revolution in the classification of mental illness. Journal of the History of the Behavioral Sciences, 41(3), 249–267. https://doi.org/10.1002/jhbs.20103
  • Mays, V., & Cochran, S. (2001). Mental health correlates of perceived discrimination among lesbian, gay, and bisexual adults in the United States. American Journal of Public Health, 91(11), 1869–1876. https://doi.org/10.2105/AJPH.91.11.1869
  • McKay, K. M., Imel, Z. E., & Wampold, B. E. (2006). Psychiatrist effects in the psychopharmacological treatment of depression. Journal of Affective Disorders, 92(2–3), 287–290. https://doi.org/10.1016/j.jad.2006.01.020
  • Mehta, S., & Farina, A. (1997). Is being ‘sick’ really better? Effect of the disease view of mental disorders on stigma. Journal of Social and Clinical Psychology, 16(4), 405–419. https://doi.org/10.1521/jscp.1997.16.4.405
  • Moncrieff, J., Wessely, S., & Hardy, R. (2004). Active placebos versus antidepressants for depression. Cochrane Database of Systematic Reviews, 1, 1–31. DOI: 10.1002/14651858.CD003012.pub2
  • Mosher, L. R., & Menn, A. Z. (1978). Community residential treatment for schizophrenia: Two-year follow-up. Hospital & Community Psychiatry, 29(11), 715–723. https://doi.org/10.1176/ps.29.11.715
  • Prien, R. F., Levine, J., & Switalski, R. W. (1971). Discontinuation of chemotherapy for chronic schizophrenics. Hospital and Community Psychiatry, 22(1), 20–23. https://doi.org/10.1176/ps.22.1.4
  • Read, J. (2013). A history of madness. In J. Read, L. Mosher, & R. Bentall (Eds.), Models of madness: Psychological, social, and biological approaches to schizophrenia (pp. 10–20). Routledge.
  • Read, J., & Masson, J. (2013). Genetics, eugenics and mass murder of ‘schizophrenics’. In J. Read, L. Mosher, & R. Bentall (Eds.), Models of madness: Psychological, social, and biological approaches to schizophrenia (pp. 35–42). Routledge.
  • Reimherr, F. W., Ward, M. F., & Byerley, W. F. (1989). The introductory placebo washout: A retrospective evaluation. Psychiatry Research, 30(2), 191–199. https://doi.org/10.1016/0165-1781(89)90160-1
  • Rogers, C. R., Gendlin, E. T., Kiesler, D. J., & Truax, C. B. (1967). The therapeutic relationship and its impact: A study of psychotherapy with schizophrenics. University of Wisconsin Press.
  • Rosenhan, D. L. (1973). On being sane in insane places. Science, 179(4070), 250–258. https://doi.org/10.1126/science.179.4070.250
  • Santayana, G. (1905). The life of reason, Volume 1. Charles Scribner’s Sons.
  • Scull, A. (2005). Madhouse: A tragic tale of megalomania and modern medicine. Yale University Press.
  • Simionato, G. K., & Simpson, S. (2018). Personal risk factors associated with burnout among psychotherapists: A systematic review of the literature. Journal of Clinical Psychology, 74(9), 1431–1456. https://doi.org/10.1002/jclp.22615
  • Sullivan, H. S. (1966). Conceptions of modern psychiatry. W. W. Norton & Company.
  • Szasz, T. S. (1960). The myth of mental illness. American Psychologist, 15(2), 113–118. https://doi.org/10.1037/h0046535
  • Timimi, S. (2014). No more psychiatric labels: Why formal psychiatric diagnostic systems should be abolished. International Journal of Clinical and Health Psychology, 14(3), 208–215. https://doi.org/10.1016/j.ijchp.2014.03.004
  • Vick, B., Jones, K., & Mitra, S. (2012). Poverty and severe psychiatric disorder in the U.S.: Evidence from the medical expenditure panel survey. Journal of Mental Health Policy and Economics, 15(2), 83–96.
  • Volavka, J., Cooper, T. B., Laska, E. M., & Meisner, M. (1996). Placebo washout in trials of antipsychotic drugs. Schizophrenia Bulletin, 22(4), 567–576. https://doi.org/10.1093/schbul/22.4.567
  • Wampold, B. E. (2015). How important are the common factors in psychotherapy? An update. World Psychiatry: Official Journal of the World Psychiatric Association, 14(3), 270–277. https://doi.org/10.1002/wps.20238
  • Waters, E. (2010). Crazy like us: The globalization of the American psyche. Free Press.
  • Whitaker, R. B. (2002). Mad in America: Bad science, bad medicine, and the enduring mistreatment of the mentally ill. Perseus Publishing.
  • Williams, D., & Mohammed, S. (2009). Discrimination and racial disparities in health: Evidence and needed research. Journal of Behavioral Medicine, 32(1), 20–47. https://doi.org/10.1007/s10865-008-9185-0
  • World Health Organization. (1973). The International Pilot Study of Schizophrenia, vol. 1. WHO.
  • World Health Organization. (1979). Schizophrenia: An international follow-up study. John Wiley and Sons Ltd.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.